ATE214932T1 - Zusammensetzungen enthaltend lazaroide und ihre verwendung zur vorbeugung von adhäsionen - Google Patents

Zusammensetzungen enthaltend lazaroide und ihre verwendung zur vorbeugung von adhäsionen

Info

Publication number
ATE214932T1
ATE214932T1 AT95939168T AT95939168T ATE214932T1 AT E214932 T1 ATE214932 T1 AT E214932T1 AT 95939168 T AT95939168 T AT 95939168T AT 95939168 T AT95939168 T AT 95939168T AT E214932 T1 ATE214932 T1 AT E214932T1
Authority
AT
Austria
Prior art keywords
compound
lazaroids
compositions containing
lipid
administered
Prior art date
Application number
AT95939168T
Other languages
English (en)
Inventor
Kathleen E Rodgers
Gere S Dizerega
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE214932T1 publication Critical patent/ATE214932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT95939168T 1994-11-17 1995-11-15 Zusammensetzungen enthaltend lazaroide und ihre verwendung zur vorbeugung von adhäsionen ATE214932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/341,651 US5614515A (en) 1994-11-17 1994-11-17 Lazaroid-based compositions and method for preventing adhesion formation using the same
PCT/US1995/014938 WO1996015795A1 (en) 1994-11-17 1995-11-15 Compositions containing lazaroids and their use for preventing adhesions

Publications (1)

Publication Number Publication Date
ATE214932T1 true ATE214932T1 (de) 2002-04-15

Family

ID=23338469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939168T ATE214932T1 (de) 1994-11-17 1995-11-15 Zusammensetzungen enthaltend lazaroide und ihre verwendung zur vorbeugung von adhäsionen

Country Status (9)

Country Link
US (1) US5614515A (de)
EP (1) EP0792153B1 (de)
JP (1) JPH10511645A (de)
AT (1) ATE214932T1 (de)
AU (1) AU692641B2 (de)
CA (2) CA2205347C (de)
DE (1) DE69526108T2 (de)
ES (1) ES2171203T3 (de)
WO (1) WO1996015795A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10505063A (ja) * 1994-09-01 1998-05-19 ファルマシア・アンド・アップジョン・カンパニー チリラザドの共溶媒非経口処方
US5866554A (en) * 1996-07-19 1999-02-02 Shalaby; Shalaby W. Compositions for prevention of inflammation and adhesion formation and uses thereof
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
CA2288913C (en) * 1997-04-22 2004-07-13 Friedrich Lampert Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
WO1999046285A2 (en) 1998-03-11 1999-09-16 University Of Southern California Method of promoting production of living tissue equivalents
US6762167B1 (en) 1998-05-11 2004-07-13 University Of Southern California Methods for treating a patient undergoing chemotherapy
CA2322963C (en) 1998-05-11 2004-04-13 University Of Southern California Methods to increase white blood cell survival after chemotherapy
DK1085920T3 (da) * 1998-05-13 2002-04-15 Ml Lab Plc Dextrinholdigt præparat til forebyggelse af kirurgiske adhæsioner
GB9810127D0 (en) 1998-05-13 1998-07-08 Ml Lab Plc Prevention of surgical adhesions
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
CA2328871C (en) 1998-07-13 2002-10-01 University Of Southern California Methods for accelerating bone and cartilage growth and repair
US6730775B1 (en) 1999-03-23 2004-05-04 University Of Southern California Methods for limiting scar and adhesion formation
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US7338938B2 (en) 1999-05-10 2008-03-04 University Of Southern California Methods for treating a patient undergoing chemotherapy
US6800298B1 (en) 2000-05-11 2004-10-05 Clemson University Biological lubricant composition and method of applying lubricant composition
ES2427930T3 (es) * 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
WO2002094321A1 (fr) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions favorisant la guérison d'une fracture osseuse
US20090227507A1 (en) * 2008-03-10 2009-09-10 University Of Southern California Angiotensin (1-7) Dosage Forms and Uses Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001706A2 (en) * 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
IN166447B (de) * 1985-11-27 1990-05-12 Ethicon Inc
US4968675A (en) * 1988-10-28 1990-11-06 Upjohn Non-hemolytic lazaroid parenteral formulation
US5256408A (en) * 1990-06-12 1993-10-26 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use

Also Published As

Publication number Publication date
EP0792153A1 (de) 1997-09-03
AU4110796A (en) 1996-06-17
US5614515A (en) 1997-03-25
CA2625906C (en) 2010-02-09
WO1996015795A1 (en) 1996-05-30
CA2625906A1 (en) 1996-05-30
DE69526108D1 (de) 2002-05-02
DE69526108T2 (de) 2002-11-21
ES2171203T3 (es) 2002-09-01
EP0792153B1 (de) 2002-03-27
JPH10511645A (ja) 1998-11-10
CA2205347C (en) 2008-10-21
AU692641B2 (en) 1998-06-11
CA2205347A1 (en) 1996-05-30

Similar Documents

Publication Publication Date Title
DE69526108D1 (de) Zusammensetzungen enthaltend lazaroide und ihre verwendung zur vorbeugung von adhäsionen
DE69634823D1 (de) Aus hyaluronsäurederivaten bestehenden biomaterialien zur hemmung der postoperativen adhäsionsbildung
NO995301L (no) Bionedbrytbare sammensetninger omfattende poly(cykloalifatisk fosfoester) forbindelser, artikler og fremgangsmåte for anvendelse derav
ATE203157T1 (de) Injizierbare depotgelzubereitung und herstellungsverfahren
BR9909283A (pt) Composição de polìmero contendo resìduo de ácido láctico, método para preparação e uso do produto
ES2183106T3 (es) Utilizacion de un vidrio laminado para la amortiguacion de vibraciones de origen solido en un vehiculo.
ITPD920088A1 (it) Uso di idrogeli per il bloccaggio di sistemi protesici
DE69129770D1 (de) Biologisch abbaubare hochmolekulare Polymere, ihre Herstellung und ihre Verwendung
ATE150469T1 (de) Mitogenfreie substanz, deren herstellung sowie verwendung
DE69826994D1 (de) Bioabbaubare terephthalat polyester-polyphosphat polymere, zusammensetzungen, gegenstände und verfahren für ihre herstellung und verwendung
KR930001898A (ko) 에어로졸 조성물
DE69416306D1 (de) Sphingoglycolipid und verwendung davon
KR940005281A (ko) 항류마티스성 조성물
DE69733171D1 (de) Isocyanatzusammensetzungen, verfahren zu deren verwendung, deren verwendung zur herstellung von beschichtungen und beschichtungen so erhalten
PT833609E (pt) Composicoes e processos para estabilizacao de polimeros
DE69305346D1 (de) Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben
DE59910304D1 (de) Zähe, dimensionsstabile und transparente folie mit copolyamidschicht enthaltend feste, nanoskalige füllstoffe mit nukleierender wirkung sowie deren verwendung zur verpackung von lebensmitteln
ATE192143T1 (de) Substituierte 2,2-dimethyl-omega-phenoxysäure und ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE59909231D1 (de) Beschlichtete Glasfasern sowie deren Verwendung
DE69411000D1 (de) Verfahren zur herstellung von beta-phenylisoserin-derivaten
SE9602617L (sv) Ortoesterbaserad polymer, förfarande för dess framställning och användning därav
FI951452A (fi) Polymeerikoostumus
EP0331876A3 (de) Geformte Artikel aus Polyamid und Verfahren zu deren Herstellung
MXPA99009317A (es) Un proceso de fragancia agradable para estabilizar polimeros que contienen halogeno.
EP0334423A3 (de) Linearer, Phosphor enthaltender Copolyester, Verfahren zu seiner Herstellung und seine Anwendung als Flammschutzmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties